Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-096403
Filing Date
2024-08-13
Accepted
2024-08-13 17:00:18
Documents
38
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tcon-20240630.htm   iXBRL 10-Q 1025987
2 EX-31.1 tcon-ex31_1.htm EX-31.1 11177
3 EX-32.1 tcon-ex32_1.htm EX-32.1 7366
  Complete submission text file 0000950170-24-096403.txt   4256968

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tcon-20240630.xsd EX-101.SCH 709043
41 EXTRACTED XBRL INSTANCE DOCUMENT tcon-20240630_htm.xml XML 654676
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Filer) CIK: 0001394319 (see all company filings)

EIN.: 342037594 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36818 | Film No.: 241202680
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)